NSN 6505-01-724-4068 · NIIN 017244068 · FSC 6505
NO DASHES 6505017244068
In Stock
ADENOSINE INJECTION
Drugs and Biologicals
Technical characteristics
10 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CQGK | SECONDARY CONTAINER TYPE | VIAL |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS ADENOSINE PER MILLILITER 3.0 |
| CSGS | ADMINISTRATION | INTRAVENOUS |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ADENOSINE INTRAVENOUS SOLUTION, 2ML VIAL, 3 MG/ML, 10S |
| FEAT | SPECIAL FEATURES | INDICATED INTRAVENOUSLY FOR THE CONVERSION TO SINUS RHYTHM OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT), INCLUDING THAT ASSOCIATED WITH ACCESSORY BYPASS TRACTS (WOLFF-PARKINSON-WHITE SYNDROME). ADENOSINE INJECTION, USP DOES NOT CONVERT ATRIAL FLUTTER, ATRIAL FIBRILLATION, OR VENTRICULAR TACHYCARDIA TO NORMAL SINUS RHYTHM; FOR RAPID BOLUS INTRAVENOUS USE; STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE); DO NOT REFRIGERATE; CONTAINS NO PRESERVATIVES; DISCARD UNUSED PORTION; CONTAINER CLOSURE IS NOT MADE WITH NATURAL RUBBER LATEX; CONTAINS 10 VIALS, 2ML SINGLE DOSE VIAL; SUPPLIED AS A STERILE, NONPYROGENIC SOLUTION IN NORMAL SALINE. |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| CBBL | FEATURES PROVIDED | STERILE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | MILLILITERS 2.0 |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |